Short answer
SI-BONE, Inc. (SIBN) filed its Q2 2026 10-Q quarterly report on Aug 4, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $56M (up 15.2% year over year) with net income of −$4M.
Q2 2026 key financials · XBRL
- Revenue
- $56M
- +15.2% YoY · +6.5% QoQ
- Net income
- −$4M
- +33.6% YoY · +5.7% QoQ
- Operating margin
- -8.6%
- Gross margin
- 79.5%
- EPS (diluted)
- −$0.09
- +40.0% YoY · +10.0% QoQ
Source: XBRL data from the SI-BONE, Inc. (SIBN) Q2 2026 10-Q on SEC EDGAR. USD.
SI-BONE, Inc. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly revenue $56.0M, up 15.2% YoY from $48.6M, driven by 14.9% higher procedure volumes
- Gross margin 79.5% vs 79.8% YoY, reflecting product mix changes
- U.S. revenue $53.2M, up 14.7%; international revenue $2.8M, up 25.9%
- Cash and marketable securities $145.9M vs $147.8M at December 31, 2025
- Six-month operating cash use $1.6M vs $4.7M; management expects funding for 12 months but cites downturn and capital-market risks
Risk Factors
- No risk-factors section provided; supplied text begins with Item 2 and contains no 10-Q risk disclosures
- CEO Rule 10b5-1 plan adopted May 21, 2026, covering up to 492,961 shares through August 31, 2027
- Third Amendment to lease dated June 5, 2026, with BIXBY SPE FINANCE 11, LLC
- No regulatory, legal, operational, competitive, market, liquidity, debt, currency, or concentration risks stated in the provided text
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other SI-BONE, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.